Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00323739
Status:
COMPLETED
Last Update Posted:
2013-07-26
First Post:
2006-05-05
Brief Title:
Bevacizumab Avastin and RAD001Everolimusin the Treatment of Advanced Clear Cell Renal Carcinoma
Sponsor:
Organization:
SCRI Development Innovations LLC